<SEC-DOCUMENT>0001214659-20-003357.txt : 20200415
<SEC-HEADER>0001214659-20-003357.hdr.sgml : 20200415
<ACCEPTANCE-DATETIME>20200415112754
ACCESSION NUMBER:		0001214659-20-003357
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200415
DATE AS OF CHANGE:		20200415
EFFECTIVENESS DATE:		20200415

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMGEN INC
		CENTRAL INDEX KEY:			0000318154
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				953540776
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37702
		FILM NUMBER:		20792997

	BUSINESS ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320
		BUSINESS PHONE:		(805)447-1000

	MAIL ADDRESS:	
		STREET 1:		ONE AMGEN CENTER DRIVE
		CITY:			THOUSAND OAKS
		STATE:			CA
		ZIP:			91320

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMGEN
		DATE OF NAME CHANGE:	19870305

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			United Church Funds, Inc.
		CENTRAL INDEX KEY:			0001739344
		IRS NUMBER:				237092477
		STATE OF INCORPORATION:			CT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		475 RIVERSIDE DRIVE
		STREET 2:		SUITE 1020
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10115
		BUSINESS PHONE:		(212) 729-2600

	MAIL ADDRESS:	
		STREET 1:		475 RIVERSIDE DRIVE
		STREET 2:		SUITE 1020
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10115
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>r414204px14a6g.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="unitedchurchfund_smlogo.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PROXY MEMORANDUM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>To: </B>Amgen Inc. Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.6in"><B>Subject:
</B>Shareholder proposal on an Independent Chair</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Date: </B>April 15, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-indent: -0.6in"><B>Contact: </B>Katie McCloskey,
Director Social Responsibility, United Church Funds, katie.mccloskey@ucfunds.org</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Gray 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We are writing to urge Amgen, Inc. (Amgen) shareholders to
VOTE FOR ITEM #4 (Independent Board Chair) on the Company&rsquo;s 2020 proxy: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Shareholders are best served by an independent board chair
who can provide the strongest form of independent oversight</B>. Amgen&rsquo;s Board should ensure rigorous oversight by adopting
best practice governance policies, including an independent board chair.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>RESOLVED</I></B><I>: The shareholders request the Board
of Directors to adopt as policy, and amend the bylaws as necessary, to require the Chair of the Board of Directors, whenever possible,
to be an independent member of the Board. This policy would be phased in for the next CEO transition. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If the Board determines that a Chair who was independent
when selected is no longer independent, the Board shall select a new Chair who satisfies the requirements of the policy within
a reasonable amount of time. Compliance with this policy is waived if no independent director is available and willing to serve
as Chair.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: windowtext">Amgen&rsquo;s Board opposes
the shareholder proposal arguing that the presence of an independent Lead Director and the existing committee structure is &ldquo;best
[to] address the Company&rsquo;s evolving and highly complex business.&rdquo;<SUP>1</SUP> However, the Lead Director (on the board
since 2012) sits on three other boards of public corporations while the company has experienced a certain degree of negative press,
namely when settling </FONT><FONT STYLE="background-color: white">federal claims that Amgen violated laws when it used charities
to pay for Medicare patients&rsquo; out-of-pocket costs for the company&rsquo;s own drugs</FONT><FONT STYLE="color: windowtext">.<SUP>2</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We believe an independent lead director is not an adequate substitute
for an independent board chairman. According to the EY Center for Board Matters, &ldquo;They do not command the same authority
as a board chair.&rdquo;<SUP>3</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> <A HREF="http://www.sec.gov/Archives/edgar/data/318154/000119312520100447/d846287ddef14a.htm">https://www.sec.gov/Archives/edgar/data/318154/000119312520100447/d846287ddef14a.htm</A>
at 94</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> https://www.wsj.com/articles/amgen-astellas-to-pay-125-million-to-settle-kickback-claims-11556210867</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> https://corpgov.law.harvard.edu/2018/11/20/todays-independent-board-leadership-landscape/</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This is not a solicitation of authority to vote your proxy.
Please DO NOT send us your proxy card as it will not be accepted. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">According to PWC&rsquo;s 2019 survey of over 700 directors,
57% of directors surveyed who sit on a board with a chair/CEO say it is difficult to voice dissent. When the chairman and CEO
are the same person, there is a greater risk that important questions will not get asked.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Council of Institutional Investors, the authoritative voice
on governance matters, supports independent chair governance because a &ldquo;CEO who also serves as a chair can exert excessive
influence on the board and its agenda.&rdquo;<SUP>4</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A CEO who also serves as the chair may exert excessive influence
on the board and its agenda, weakening the board&rsquo;s oversight of management. Separating the chair and CEO positions can reduce
this conflict, and an independent chair provides the most transparent separation of power between the CEO and the rest of the board.<SUP>5</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An in-depth report by Glass Lewis in 2016 on independent board
chairman states &ldquo;&hellip;that shareholders are better served when the board is led by an independent chairman who we believe
is better able to oversee the executives of the Company and set a pro-shareholder agenda without the management conflicts that
exists when a CEO or other executive also serves as chairman. This, in turn, leads to a more proactive and effective board of directors.&rdquo;<SUP>6</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to ensure that our Board can provide rigorous oversight
and transparency and ensure greater independence and accountability, we urge a vote FOR this shareholder proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>4</SUP> https://www.cii.org/independent_board</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>5</SUP> Ibid</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>6</SUP> http://www.glasslewis.com/wp-content/uploads/2016/03/2016-In-Depth-Report-INDEPENDENT-BOARD-CHAIRMAN.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This is not a solicitation of authority to vote your proxy.
Please DO NOT send us your proxy card as it will not be accepted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV>

<DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>unitedchurchfund_smlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 unitedchurchfund_smlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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MSL]$NCW=CWJBOHC@"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
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M#XV_#_X@^-?AO\+?$M_=?#WQ/>:#=Z"(X!=:C=VZ1.PM_P!YM(82C;O*G@Y
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M_P 8/VP/ _P:\-?#OQ-XA\)ZY-'\2?$%CI&CV\-LB36LUU"TL9G21U* *I#
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MS2M:TV"_TV[C!VSV\T:R1N,]BK _C2EW1.6U:T+X6LO>@E9])1V3_#4^??\
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MVE-[\J_(QQ4>3$32[L**] YPHH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "@C(H ^.?VQO#>B:1^W?\,/%?CO2;:Z\/ZS#'87
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M",8145LCA;<G=A15 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
*!10 44 %% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
